Trials / Completed
CompletedNCT01374347
Brain SPECT Following Cialis (Tadalafil ) Administration
Brain SPECT Perfusion Imaging Following Cialis (Tadalafil ) Administration in Patients With Vascular Risk Factors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Wolfson Medical Center · Other Government
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study will be an open label one and will include 30 patients who underwent ischemic stroke 3 month to 3 years prior to the study. All patients will undergone a baseline brain SPECT perfusion study. 15 patients will take one dose of 20 mg cialis, and will have a second brain SPECT 24 hours after cialis administration. 15 other patients (age and risk factor matched) will be prescribed 5 mg of cialis once daily for 7 days, and a second SPECT study will be performed 24 hours after the last dose.
Conditions
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-06-15
- Last updated
- 2016-02-09
Source: ClinicalTrials.gov record NCT01374347. Inclusion in this directory is not an endorsement.